Hi everyone. I prepped some samples with Nextera xt kit and run them on the next seq. I monitored the run and everything was fine until the uploading step. I can see cluster density, %pf and %q30, and in the run completion file it says CompletedAsPlanned. So I don't understand why in the status it says Failed. Can you guys help me troubleshooting? Seems like nothing has gone wrong.
-
-
Sounds like you do your analysis in BaseSpace? Was there a network failure of some kind?
Your best bet is to engage Illumina techsupport but someone else who uses BaseSpace may be able to help. -
I use basespace to monitor the run status remotely and also to download the fastq file because the nextseq machine is shared with other people so we use it just to set up the sequencing. I just don't understand why it stopped. I can actually see a fastq file generated but the size is small probably because it has data just for a few samples?Comment
-
This has happened to me with the MiSeq and it was a problem with the sample sheet that kept the run from demuxing. If this is what happened then the error log will tell you which lines of your sheet need to be fixed.Josh KinmanComment
-
Thank you jdk787. I have double checked the sample sheet and this is fine. I can't see any error log file, could you please remind me where to look for it please?Comment
-
Issue solved. There was a network failure so I requeued the analysis and now it's fine!!Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment